Selected research
Industry Growth & Trends
Global AI Drug Discovery Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI Drug Discovery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI Drug Discovery market include Recursion, Insilico Medicine, Schrödinger, DeepMind, Insitro, Generate Biomedicines, XtalPi, Relay Therapeutics and BenevolentAI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI Drug Discovery market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI Drug Discovery market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Drug Discovery market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Drug Discovery.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI Drug Discovery market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI Drug Discovery Market by Company
Recursion
Insilico Medicine
Schrödinger
DeepMind
Insitro
Generate Biomedicines
XtalPi
Relay Therapeutics
BenevolentAI
Roivant Sciences
Ginkgo Bioworks
Exscientia
Merck KGaA
Novartis
Biotus
Huazhi Bio
MindRank AI
Ubigene
WuXi AppTec
AI Drug Discovery Segment by Type
Machine Learning Type
Deep Learning Type
Natural Language Processing Type
Data Mining Type
AI Drug Discovery Segment by Application
Target Discovery and Validation
Virtual Screening and Molecular Docking
Drug Repurposing and Precision Medicine
Clinical Data Analysis and Optimization
AI Drug Discovery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI Drug Discovery companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Machine Learning Type
- Deep Learning Type
- Natural Language Processing Type
- Data Mining Type
Applications
- Target Discovery and Validation
- Virtual Screening and Molecular Docking
- Drug Repurposing and Precision Medicine
- Clinical Data Analysis and Optimization
Companies covered
- Recursion
- Insilico Medicine
- Schrödinger
- DeepMind
- Insitro
- Generate Biomedicines
- XtalPi
- Relay Therapeutics
- BenevolentAI
- Roivant Sciences
- Ginkgo Bioworks
- Exscientia
- Merck KGaA
- Novartis
- Biotus
- Huazhi Bio
- MindRank AI
- Ubigene
- WuXi AppTec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI Drug Discovery Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI Drug Discovery Market Size by Region (2021-2032)
- 1.4.1 Global AI Drug Discovery Market Size by Region (2021-2026)
- 1.4.2 Global AI Drug Discovery Market Size by Region (2027-2032)
- 1.5 Key Regions AI Drug Discovery Market Size (2021-2032)
- 1.5.1 North America AI Drug Discovery Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI Drug Discovery Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI Drug Discovery Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI Drug Discovery Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI Drug Discovery Market Size Growth Rate (2021-2032)
2 AI Drug Discovery Market by Type
- 2.1 Type Introduction
- 2.1.1 Machine Learning Type
- 2.1.2 Deep Learning Type
- 2.1.3 Natural Language Processing Type
- 2.1.4 Data Mining Type
- 2.2 Global AI Drug Discovery Market Size by Type
- 2.2.1 Global AI Drug Discovery Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI Drug Discovery Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI Drug Discovery Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI Drug Discovery Market Size by Regions
- 2.3.1 North America AI Drug Discovery Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI Drug Discovery Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI Drug Discovery Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI Drug Discovery Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI Drug Discovery Market Size Breakdown by Type (2021-2026)
3 AI Drug Discovery Market by Application
- 3.1 Type Introduction
- 3.1.1 Target Discovery and Validation
- 3.1.2 Virtual Screening and Molecular Docking
- 3.1.3 Drug Repurposing and Precision Medicine
- 3.1.4 Clinical Data Analysis and Optimization
- 3.2 Global AI Drug Discovery Market Size by Application
- 3.2.1 Global AI Drug Discovery Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI Drug Discovery Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI Drug Discovery Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI Drug Discovery Market Size by Regions
- 3.3.1 North America AI Drug Discovery Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI Drug Discovery Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI Drug Discovery Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI Drug Discovery Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI Drug Discovery Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI Drug Discovery Industry Trends
- 4.2 AI Drug Discovery Industry Drivers
- 4.3 AI Drug Discovery Industry Opportunities and Challenges
- 4.4 AI Drug Discovery Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI Drug Discovery Revenue (2021-2026)
- 5.2 Global AI Drug Discovery Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI Drug Discovery Key Company Headquarters & Area Served
- 5.4 Global AI Drug Discovery Company, Product Type & Application
- 5.5 Global AI Drug Discovery Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI Drug Discovery Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI Drug Discovery Players Market Share by Revenue in 2025
- 5.6.3 2025 AI Drug Discovery Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Recursion
- 6.1.1 Recursion Company Information
- 6.1.2 Recursion Business Overview
- 6.1.3 Recursion AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Recursion AI Drug Discovery Product Portfolio
- 6.1.5 Recursion Recent Developments
- 6.2 Insilico Medicine
- 6.2.1 Insilico Medicine Company Information
- 6.2.2 Insilico Medicine Business Overview
- 6.2.3 Insilico Medicine AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Insilico Medicine AI Drug Discovery Product Portfolio
- 6.2.5 Insilico Medicine Recent Developments
- 6.3 Schrödinger
- 6.3.1 Schrödinger Company Information
- 6.3.2 Schrödinger Business Overview
- 6.3.3 Schrödinger AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Schrödinger AI Drug Discovery Product Portfolio
- 6.3.5 Schrödinger Recent Developments
- 6.4 DeepMind
- 6.4.1 DeepMind Company Information
- 6.4.2 DeepMind Business Overview
- 6.4.3 DeepMind AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 DeepMind AI Drug Discovery Product Portfolio
- 6.4.5 DeepMind Recent Developments
- 6.5 Insitro
- 6.5.1 Insitro Company Information
- 6.5.2 Insitro Business Overview
- 6.5.3 Insitro AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Insitro AI Drug Discovery Product Portfolio
- 6.5.5 Insitro Recent Developments
- 6.6 Generate Biomedicines
- 6.6.1 Generate Biomedicines Company Information
- 6.6.2 Generate Biomedicines Business Overview
- 6.6.3 Generate Biomedicines AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Generate Biomedicines AI Drug Discovery Product Portfolio
- 6.6.5 Generate Biomedicines Recent Developments
- 6.7 XtalPi
- 6.7.1 XtalPi Company Information
- 6.7.2 XtalPi Business Overview
- 6.7.3 XtalPi AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 XtalPi AI Drug Discovery Product Portfolio
- 6.7.5 XtalPi Recent Developments
- 6.8 Relay Therapeutics
- 6.8.1 Relay Therapeutics Company Information
- 6.8.2 Relay Therapeutics Business Overview
- 6.8.3 Relay Therapeutics AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Relay Therapeutics AI Drug Discovery Product Portfolio
- 6.8.5 Relay Therapeutics Recent Developments
- 6.9 BenevolentAI
- 6.9.1 BenevolentAI Company Information
- 6.9.2 BenevolentAI Business Overview
- 6.9.3 BenevolentAI AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 BenevolentAI AI Drug Discovery Product Portfolio
- 6.9.5 BenevolentAI Recent Developments
- 6.10 Roivant Sciences
- 6.10.1 Roivant Sciences Company Information
- 6.10.2 Roivant Sciences Business Overview
- 6.10.3 Roivant Sciences AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Roivant Sciences AI Drug Discovery Product Portfolio
- 6.10.5 Roivant Sciences Recent Developments
- 6.11 Ginkgo Bioworks
- 6.11.1 Ginkgo Bioworks Company Information
- 6.11.2 Ginkgo Bioworks Business Overview
- 6.11.3 Ginkgo Bioworks AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Ginkgo Bioworks AI Drug Discovery Product Portfolio
- 6.11.5 Ginkgo Bioworks Recent Developments
- 6.12 Exscientia
- 6.12.1 Exscientia Company Information
- 6.12.2 Exscientia Business Overview
- 6.12.3 Exscientia AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Exscientia AI Drug Discovery Product Portfolio
- 6.12.5 Exscientia Recent Developments
- 6.13 Merck KGaA
- 6.13.1 Merck KGaA Company Information
- 6.13.2 Merck KGaA Business Overview
- 6.13.3 Merck KGaA AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Merck KGaA AI Drug Discovery Product Portfolio
- 6.13.5 Merck KGaA Recent Developments
- 6.14 Novartis
- 6.14.1 Novartis Company Information
- 6.14.2 Novartis Business Overview
- 6.14.3 Novartis AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Novartis AI Drug Discovery Product Portfolio
- 6.14.5 Novartis Recent Developments
- 6.15 Biotus
- 6.15.1 Biotus Company Information
- 6.15.2 Biotus Business Overview
- 6.15.3 Biotus AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Biotus AI Drug Discovery Product Portfolio
- 6.15.5 Biotus Recent Developments
- 6.16 Huazhi Bio
- 6.16.1 Huazhi Bio Company Information
- 6.16.2 Huazhi Bio Business Overview
- 6.16.3 Huazhi Bio AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Huazhi Bio AI Drug Discovery Product Portfolio
- 6.16.5 Huazhi Bio Recent Developments
- 6.17 MindRank AI
- 6.17.1 MindRank AI Company Information
- 6.17.2 MindRank AI Business Overview
- 6.17.3 MindRank AI AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 MindRank AI AI Drug Discovery Product Portfolio
- 6.17.5 MindRank AI Recent Developments
- 6.18 Ubigene
- 6.18.1 Ubigene Company Information
- 6.18.2 Ubigene Business Overview
- 6.18.3 Ubigene AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Ubigene AI Drug Discovery Product Portfolio
- 6.18.5 Ubigene Recent Developments
- 6.19 WuXi AppTec
- 6.19.1 WuXi AppTec Company Information
- 6.19.2 WuXi AppTec Business Overview
- 6.19.3 WuXi AppTec AI Drug Discovery Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 WuXi AppTec AI Drug Discovery Product Portfolio
- 6.19.5 WuXi AppTec Recent Developments
7 North America
- 7.1 North America AI Drug Discovery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI Drug Discovery Market Size by Country (2021-2026)
- 7.3 North America AI Drug Discovery Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI Drug Discovery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI Drug Discovery Market Size by Country (2021-2026)
- 8.3 Europe AI Drug Discovery Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI Drug Discovery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI Drug Discovery Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI Drug Discovery Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI Drug Discovery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI Drug Discovery Market Size by Country (2021-2026)
- 10.3 South America AI Drug Discovery Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI Drug Discovery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI Drug Discovery Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI Drug Discovery Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst